{"id":"https://openalex.org/W2245193063","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.1030","title":"Correlation between quantitative HER2 protein level and the risk of brain metastasis (BM) in patients (pts) with metastatic breast cancer (MBC) treated with trastuzumab-containing therapy.","display_name":"Correlation between quantitative HER2 protein level and the risk of brain metastasis (BM) in patients (pts) with metastatic breast cancer (MBC) treated with trastuzumab-containing therapy.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2245193063","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.1030","mag":"2245193063"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.1030","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.1030","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.1030","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045464653","display_name":"Renata Duchnowska","orcid":"https://orcid.org/0000-0002-9272-3462","observed_orcids":["https://orcid.org/0000-0002-9272-3462"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Duchnowska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089705899","display_name":"Barbara Szostakiewicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Szostakiewicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114549855","display_name":"Tomasz Jankowski","orcid":"https://orcid.org/0000-0002-0049-7673","observed_orcids":["https://orcid.org/0000-0002-0049-7673"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Jankowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017935878","display_name":"Bogumi\u0142a Czartoryska-Ar\u0142ukowicz","orcid":"https://orcid.org/0009-0008-8945-133X","observed_orcids":["https://orcid.org/0009-0008-8945-133X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Arlukowicz-Czartoryska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073752190","display_name":"Piotr Jan Wysocki","orcid":"https://orcid.org/0000-0003-4003-5278","observed_orcids":["https://orcid.org/0000-0003-4003-5278"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. J. Wysocki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057765611","display_name":"Wei-Feng Huang","orcid":"https://orcid.org/0000-0002-9755-7299","observed_orcids":["https://orcid.org/0000-0002-9755-7299"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111966562","display_name":"Michael Patrick Bates","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. P. Bates","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108623958","display_name":"JM Weidler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Weidler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M. Haddad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Haddad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004874011","display_name":"Jacek Jassem","orcid":"https://orcid.org/0000-0002-8875-6747","observed_orcids":["https://orcid.org/0000-0002-8875-6747","https://orcid.org/0000-0003-1482-6068"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Jassem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"1030","last_page":"1030"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.06270000338554382,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-expression","display_name":"HER2 expression","score":0.8009999990463257},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.777999997138977},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8790000081062317},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9559999704360962},{"id":"https://openalex.org/keywords/her2-cep17-ratio","display_name":"HER2/CEP17 ratio","score":0.9430000185966492},{"id":"https://openalex.org/keywords/fluorescence-in-situ-hybridization","display_name":"fluorescence in situ hybridization","score":0.8270000219345093},{"id":"https://openalex.org/keywords/tumor-grade","display_name":"tumor grade","score":0.7279999852180481},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.8029999732971191},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.5989999771118164},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8297253847122192},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.785097599029541},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7182646989822388},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5725474953651428},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.5656181573867798},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5478451251983643},{"id":"https://openalex.org/C2781303241","wikidata":"https://www.wikidata.org/wiki/Q17165041","display_name":"Polysomy","level":5,"score":0.5417443513870239},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5391931533813477},{"id":"https://openalex.org/C2777542201","wikidata":"https://www.wikidata.org/wiki/Q1336182","display_name":"Fluorescence in situ hybridization","level":4,"score":0.5077096223831177},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.5054824352264404},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4967363476753235},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44661563634872437},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14320945739746094},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.1030","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.1030","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.1030","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1985365443","https://openalex.org/W2126231395","https://openalex.org/W2142329860","https://openalex.org/W2597105685","https://openalex.org/W2152621900","https://openalex.org/W2034161155","https://openalex.org/W2069163378","https://openalex.org/W2280689813","https://openalex.org/W1967109331","https://openalex.org/W2243661737"],"abstract_inverted_index":{"1030":[0],"Background:":[1],"Breast":[2],"cancer":[3,29],"is":[4,21],"estimated":[5],"to":[6,39,138,291],"be":[7],"the":[8,41,69,112,167,211,240,256,271,286,302],"second":[9],"most":[10],"frequent":[11],"cause":[12],"of":[13,18,71,77,181,214,242,273,283,296,304,311],"BM;":[14],"however":[15],"biological":[16],"basis":[17],"this":[19],"phenomenon":[20],"not":[22,191,199,247],"well":[23],"established.":[24],"Pts":[25],"with":[26,79,82,126,145,156,175,204,277,313],"HER2-overexpressing":[27],"breast":[28,49],"are":[30],"at":[31],"greater":[32],"risk":[33,70,272],"for":[34,159,308],"BM.":[35,131,149,234],"This":[36],"study":[37],"sought":[38],"investigate":[40],"correlation":[42,220],"between":[43,202,221,265],"quantitative":[44,55,266,294],"HER2":[45,54,102,108,122,140,227,243,251,267,284,297],"expression":[46,109,252,268,299],"in":[47,73,97,115,239,249,275,320],"primary":[48],"cancers":[50],"using":[51],"a":[52,74,263],"novel":[53],"assay":[56,114,164],"(the":[57],"HERmark":[58,113,257],"assay;":[59],"Joensuu":[60],"H.":[61],"et":[62],"al,":[63],"2008":[64],"SABCS,":[65],"abstract":[66],"2071)":[67],"and":[68,101,130,133,148,162,179,184,193,230,270],"BM":[72,182,274],"consecutive":[75],"series":[76],"pts":[78,312],"MBC":[80],"treated":[81],"trastuzumab-containing":[83],"therapy.":[84],"Methods:":[85],"HER2/neu":[86],"gene":[87,244],"was":[88,104,217],"quantified":[89,105],"as":[90,106,210,253,289],"HER2/CEP17":[91,188,222],"ratio":[92,224],"by":[93,111,255],"central":[94,157],"lab":[95],"fluorescence":[96],"situ":[98],"hybridization":[99],"(FISH)":[100],"protein":[103,298],"total":[107,226],"(H2T)":[110],"126":[116],"formalin-fixed,":[117],"paraffin-embedded":[118],"(FFPE)":[119],"tumor":[120,127,146,177,231],"samples.":[121],"results":[123,141],"were":[124,136,173,190,198],"correlated":[125],"histologic":[128],"grade":[129,147,178,232],"Mann-Whitney":[132],"Kruskal-Wallis":[134],"tests":[135],"performed":[137],"compare":[139],"(as":[142],"continuous":[143],"variables)":[144],"Results:":[150],"HER":[151],"mark":[152],"showed":[153],"93%":[154],"concordance":[155],"FISH":[158,223],"categorical":[160],"positive":[161],"negative":[163],"values,":[165],"excluding":[166],"equivocal":[168],"cases.":[169],"Higher":[170],"H2T":[171,196],"levels":[172,197,269],"associated":[174],"higher":[176,250],"occurrence":[180],"(p=0.04":[183],"0.03,":[185],"respectively),":[186],"whereas":[187],"ratios":[189],"(p=0.09":[192],"0.24,":[194],"respectively).":[195],"significantly":[200],"different":[201],"cases":[203],"soft":[205],"tissue,":[206],"bone,":[207],"or":[208,225,233,326,330],"viscera":[209],"dominant":[212],"site":[213],"metastasis.":[215],"There":[216],"no":[218],"significant":[219],"copy":[228],"number":[229],"Polysomy":[235],"17":[236],"(by":[237],"FISH)":[238],"absence":[241],"amplification":[245],"did":[246],"result":[248],"evaluated":[254],"assay.":[258],"Conclusions:":[259],"These":[260,316],"data":[261,317],"suggest":[262],"relationship":[264],"patients":[276],"MBC.":[278,315],"Since":[279],"small":[280],"molecule":[281],"inhibitors":[282],"cross":[285],"blood-brain":[287],"barrier":[288],"opposed":[290],"monoclonal":[292],"antibodies,":[293],"assessments":[295],"may":[300],"facilitate":[301],"refinement":[303],"therapeutic":[305],"treatment":[306],"strategies":[307],"selected":[309],"subpopulations":[310],"HER2-positive":[314],"require":[318],"confirmation":[319],"further":[321],"studies.":[322],"Author":[323],"Disclosure":[324],"Employment":[325],"Leadership":[327],"Position":[328],"Consultant":[329],"Advisory":[331],"Role":[332],"Stock":[333],"Ownership":[334],"Honoraria":[335],"Research":[336],"Funding":[337],"Expert":[338],"Testimony":[339],"Other":[340],"Remuneration":[341],"Monogram":[342],"Biosciences":[343]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}